| manufacturer_name | ndc_number | drug_product_description | date_introduced_to_market | wac_at_introduction | marketing_pricing_plan_description | marketing_pricing_plan_non_public_indicator | estimated_number_of_patients | breakthrough_therapy_indicator | priority_review_indicator | acquisition_date | acquisition_price | acquisition_price_non_public_indicator | acquisition_price_comment | general_comments | supporting_documents |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| QBioMed Inc. | 72928008901 | STRONTIUM CHLORIDE Sr-89 INJECTION, USP | 2020-05-01 | 15000.0000 | None | 1 | 2000 | None | None | 2020-09-06 | 2252913.0000 | None | Acquisition price includes global license and additional acquisition-related expenses. | None | None |